Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Proc Natl Acad Sci U S A ; 96(23): 13336-41, 1999 Nov 09.
Article in English | MEDLINE | ID: mdl-10557321

ABSTRACT

A role for glycoprotein (GP)V in platelet function has been proposed on the basis of observations that GP V is the major thrombin substrate on intact platelets cleaved during thrombin-induced platelet aggregation, and that GP V promotes GP Ib-IX surface expression in heterologous cells. We tested the hypotheses that GP V is involved in thrombin-induced platelet activation, in GP Ib-IX expression, and in other platelet responses by generating GP V null mice. Contrary to expectations, GP V -/- platelets were normal in size and expressed normal amounts of GP Ib-IX that was functional in von Willebrand factor binding, explaining why defects in GP V have not been observed in Bernard-Soulier syndrome, a bleeding disorder caused by a lack of functional GP Ib-IX-V. Moreover, in vitro analysis demonstrated that GP V -/- platelets were hyperresponsive to thrombin, resulting in increased fibrinogen binding and an increased aggregation response. Consistent with these findings, GP V -/- mice had a shorter bleeding time. These data support a role for GP V as a negative modulator of platelet activation. Furthermore, they suggest a new mechanism by which thrombin enhances platelet responsiveness independent of activation of the classical G-protein-coupled thrombin receptors.


Subject(s)
Blood Platelets/physiology , Platelet Membrane Glycoproteins/genetics , Thrombin/physiology , Animals , Bleeding Time , Gene Deletion , Mice , Mice, Knockout , Molecular Sequence Data , Platelet Membrane Glycoproteins/chemistry , Platelet Membrane Glycoproteins/physiology
2.
Chromosome Res ; 6(5): 397-404, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9872669

ABSTRACT

We analyzed an X-linked metallothionein-vasopressin (MTVP) fusion transgene that undergoes X-chromosome inactivation (X inactivation) and an X-linked transferrin (TFN) transgene that escapes X inactivation with respect to methylation in the 5' regulatory regions. The MTVP transgene promoter region is unmethylated when the transgene is on the active X chromosome and methylated when on the inactive X chromosome. Interestingly, the MTVP transgene is not detectably transcribed from the male X chromosome, although it is unmethylated, consistent with its availability for transcription. The TFN transgene promoter region is hypomethylated on both the active and inactive X chromosomes, consistent with its expression from both chromosomes. The TFN and MTVP transgenes have been mapped to chromosomal regions D and C, respectively, by fluorescence in situ hybridization. These observations are discussed in the context of our understanding of the role of DNA methylation in the spread and maintenance of X-chromosome inactivation.


Subject(s)
DNA Methylation , Dosage Compensation, Genetic , Transgenes/genetics , Animals , Artificial Gene Fusion , Blotting, Northern , Chromosome Mapping , DNA Probes , Female , Genomic Imprinting , In Situ Hybridization, Fluorescence , Male , Metallothionein/genetics , Metallothionein/metabolism , Mice , Mice, Inbred C57BL , Promoter Regions, Genetic , Transferrin/genetics , Transferrin/metabolism , Vasopressins/genetics , Vasopressins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...